These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 33024305)
1. Refined diagnosis of hydatidiform moles with p57 immunohistochemistry and molecular genotyping: updated analysis of a prospective series of 2217 cases. Xing D; Adams E; Huang J; Ronnett BM Mod Pathol; 2021 May; 34(5):961-982. PubMed ID: 33024305 [TBL] [Abstract][Full Text] [Related]
2. Characteristics of hydatidiform moles: analysis of a prospective series with p57 immunohistochemistry and molecular genotyping. Banet N; DeScipio C; Murphy KM; Beierl K; Adams E; Vang R; Ronnett BM Mod Pathol; 2014 Feb; 27(2):238-54. PubMed ID: 23887308 [TBL] [Abstract][Full Text] [Related]
3. Diagnosis and subclassification of hydatidiform moles using p57 immunohistochemistry and molecular genotyping: validation and prospective analysis in routine and consultation practice settings with development of an algorithmic approach. McConnell TG; Murphy KM; Hafez M; Vang R; Ronnett BM Am J Surg Pathol; 2009 Jun; 33(6):805-17. PubMed ID: 19145201 [TBL] [Abstract][Full Text] [Related]
4. Loss of p57 Expression in Conceptions Other Than Complete Hydatidiform Mole: A Case Series With Emphasis on the Etiology, Genetics, and Clinical Significance. Xing D; Miller K; Beierl K; Ronnett BM Am J Surg Pathol; 2022 Jan; 46(1):18-32. PubMed ID: 34074808 [TBL] [Abstract][Full Text] [Related]
5. Characterization of androgenetic/biparental mosaic/chimeric conceptions, including those with a molar component: morphology, p57 immnohistochemistry, molecular genotyping, and risk of persistent gestational trophoblastic disease. Lewis GH; DeScipio C; Murphy KM; Haley L; Beierl K; Mosier S; Tandy S; Cohen DS; Lytwyn A; Elit L; Vang R; Ronnett BM Int J Gynecol Pathol; 2013 Mar; 32(2):199-214. PubMed ID: 23370656 [TBL] [Abstract][Full Text] [Related]
6. Complete hydatidiform mole with retained maternal chromosomes 6 and 11. McConnell TG; Norris-Kirby A; Hagenkord JM; Ronnett BM; Murphy KM Am J Surg Pathol; 2009 Sep; 33(9):1409-15. PubMed ID: 19542869 [TBL] [Abstract][Full Text] [Related]
7. Diagnostic reproducibility of hydatidiform moles: ancillary techniques (p57 immunohistochemistry and molecular genotyping) improve morphologic diagnosis for both recently trained and experienced gynecologic pathologists. Gupta M; Vang R; Yemelyanova AV; Kurman RJ; Li FR; Maambo EC; Murphy KM; DeScipio C; Thompson CB; Ronnett BM Am J Surg Pathol; 2012 Dec; 36(12):1747-60. PubMed ID: 22992698 [TBL] [Abstract][Full Text] [Related]
8. Twin/Multiple Gestations With a Hydatidiform Mole: Clinicopathologic Analysis of 21 Cases With Emphasis on Molecular Genotyping and Parental Contribution. Xing D; Adams E; Zou YS; Morsberger L; Scanga LR; Gao FF; Barker N; Vang R; Ronnett BM Am J Surg Pathol; 2022 Sep; 46(9):1180-1195. PubMed ID: 35796652 [TBL] [Abstract][Full Text] [Related]
12. Diandric triploid hydatidiform mole with loss of maternal chromosome 11. DeScipio C; Haley L; Beierl K; Pandit AP; Murphy KM; Ronnett BM Am J Surg Pathol; 2011 Oct; 35(10):1586-91. PubMed ID: 21881485 [TBL] [Abstract][Full Text] [Related]
13. Recurrent Androgenetic Complete Hydatidiform Moles with p57 Li MW; Li F; Cheng J; Wang F; Zhou P Reprod Sci; 2022 Jun; 29(6):1749-1755. PubMed ID: 34606065 [TBL] [Abstract][Full Text] [Related]
14. DNA Genotyping of Nonmolar Donor Egg Pregnancies With Abnormal Villous Morphology: Allele Zygosity Patterns Prevent Misinterpretation as Complete Hydatidiform Mole. Joseph NM; Pineda C; Rabban JT Int J Gynecol Pathol; 2018 Mar; 37(2):191-197. PubMed ID: 28463912 [TBL] [Abstract][Full Text] [Related]
15. "While there is p57, there is hope." The past and the present of diagnosis in first trimester abortions: Diagnostic dilemmas and algorithmic approaches. A review. Giacometti C; Bellan E; Ambrosi A; Dei Tos AP; Cassaro M; Ludwig K Placenta; 2021 Dec; 116():31-37. PubMed ID: 33714612 [TBL] [Abstract][Full Text] [Related]
16. The usefulness of p57(KIP2) immunohistochemical staining and genotyping test in the diagnosis of the hydatidiform mole. Landolsi H; Missaoui N; Brahem S; Hmissa S; Gribaa M; Yacoubi MT Pathol Res Pract; 2011 Aug; 207(8):498-504. PubMed ID: 21767919 [TBL] [Abstract][Full Text] [Related]
17. Genetics of gestational trophoblastic disease. Fisher RA; Maher GJ Best Pract Res Clin Obstet Gynaecol; 2021 Jul; 74():29-41. PubMed ID: 33685819 [TBL] [Abstract][Full Text] [Related]
18. Tetraploid partial hydatidiform mole: a case report and review of the literature. Murphy KM; Descipio C; Wagenfuehr J; Tandy S; Mabray J; Beierl K; Micetich K; Libby AL; Ronnett BM Int J Gynecol Pathol; 2012 Jan; 31(1):73-9. PubMed ID: 22123726 [TBL] [Abstract][Full Text] [Related]
19. Heterozygous/dispermic complete mole confers a significantly higher risk for post-molar gestational trophoblastic disease. Zheng XZ; Qin XY; Chen SW; Wang P; Zhan Y; Zhong PP; Buza N; Jin YL; Wu BQ; Hui P Mod Pathol; 2020 Oct; 33(10):1979-1988. PubMed ID: 32404958 [TBL] [Abstract][Full Text] [Related]
20. p57-discordant villi in hydropic products of conception: a clinicopathological study of 70 cases. Gaillot-Durand L; Patrier S; Aziza J; Devisme L; Riera AC; Marcorelles P; Pelluard F; Gasser B; Mauduit C; Hajri T; Massardier J; Bolze PA; Golfier F; Devouassoux-Shisheboran M; Allias F Hum Pathol; 2020 Jul; 101():18-30. PubMed ID: 32387104 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]